NMDA Receptor Modulation for Bipolarity type I
This study is recruiting. It focuses on bipolarity and currently lists participation information in Taiwan.
In Taichung
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting. It focuses on bipolarity and currently lists participation information in Taiwan.
In TaichungThis study is recruiting. It focuses on depression and currently lists participation information in China.
In ShanghaiThis study is recruiting. It focuses on schizophrenia and currently lists participation information in Norway.
In OsloThis study is recruiting. It focuses on bipolarity and currently lists participation information in France.
In PoitiersThis study is recruiting. It focuses on bipolarity and currently lists participation information in Spain.
In SpainThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on depression and currently lists participation information in Sweden.
In ÖrebroThis study is recruiting. It focuses on bipolarity and currently lists participation information in Sweden.
In GothenburgThis study is recruiting. It focuses on bipolarity and currently lists participation information in Brazil.
In BrazilThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting. It focuses on bipolarity and currently lists participation information in the United Kingdom.
In United KingdomThis study is recruiting in the United Kingdom. It focuses on schizophrenia.
In United KingdomHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.